Page 3 - Beyondspring Inc News Today

MARKET WRAPS Watch For: PPI for May; Fed interest-rate decision, economic projection; EIA Weekly Petroleum Status Report; Lennar earnings Todays Headlines/Must Reads - Stock Market to Fed: You Havent Done Enough - American Investm...

Kura Oncology (NASDAQ:KURA – Get Rating) and BeyondSpring (NASDAQ:BYSI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability. Insider and Institutional Ownership 18.1% of BeyondSpring shares are held […]

Where Is the U.S. Economy Headed? Follow the Money The stock market is near a one-year high, giving many investors comfort. But down below, debt markets are creaking under the strain of rising interest rates. Lending conditions for companies, c... | 05:59am

BeyondSpring Inc. (NASDAQ:BYSI – Get Rating) shares dropped 4.3% on Tuesday . The company traded as low as $1.10 and last traded at $1.10. Approximately 69,799 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 229,329 shares. The stock had previously closed at $1.15. Analyst Ratings Changes Separately, […]

The Nasdaq Composite is now leading the Dow Jones Industrial Average by 18.3%, its widest margin of outperformance since 1991 as of Tuesday's close while the blue-chip gauge erases its year-to-date gain, according to Dow Jones Market Data. After fa... | 06:19am

BeyondSpring (NASDAQ:BYSI – Get Rating) and Mateon Therapeutics (OTCMKTS:MATN – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Earnings and Valuation This table compares BeyondSpring and Mateon Therapeutics’ […]

BeyondSpring (NASDAQ:BYSI – Get Rating) and Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Risk & Volatility BeyondSpring has a beta of 0.09, indicating […]

Mateon Therapeutics (OTCMKTS:MATN – Get Rating) and BeyondSpring (NASDAQ:BYSI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings. Earnings & Valuation This table compares Mateon Therapeutics and BeyondSpring’s […]

BeyondSpring (NASDAQ:BYSI – Get Rating) and Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, dividends, earnings and profitability. Profitability This table compares BeyondSpring and Enlivex Therapeutics’ net margins, […]

BeyondSpring (NASDAQ:BYSI – Get Rating) had its target price cut by analysts at Robert W. Baird from $4.00 to $1.25 in a research report issued to clients and investors on Tuesday, The Fly reports. Robert W. Baird’s price objective suggests a potential upside of 39.98% from the stock’s previous close. BeyondSpring Stock Down 5.6 % […]